Neuropeptide Y (NPY) antagonists are a class of compounds that inhibit the action of neuropeptide Y, a peptide involved in various physiological processes, including appetite regulation, stress response, and circadian rhythms. The specific compound with the CAS number 158859-98-4 is known for its role in research related to obesity, anxiety, and other metabolic disorders. Characteristics of this substance typically include its molecular structure, which may feature specific functional groups that facilitate binding to NPY receptors, thereby blocking their activity. The compound is often evaluated for its potency, selectivity, and efficacy in preclinical studies. Additionally, it may exhibit pharmacokinetic properties such as absorption, distribution, metabolism, and excretion (ADME) that are crucial for its potential therapeutic applications. Safety profiles, including toxicity and side effects, are also important considerations in the development of NPY antagonists. Overall, this compound represents a significant area of interest in neuropharmacology and metabolic research.

Neuropeptide Y antagonist

158859-98-4: Neuropeptide Y (NPY) antagonists are a class of compounds that inhibit the action of neuropeptide Y, a peptide involved in various physiological processes, including appetite regulation, stress response, and circadian rhythms. The specific compound with the CAS number 158859-98-4 is known for its role in research related to obesity, anxiety, and other metabolic disorders. Characteristics of this substance typically include its molecular structure, which may feature specific functional groups that facilitate binding to NPY receptors, thereby blocking their activity. The compound is often evaluated for its potency, selectivity, and efficacy in preclinical studies. Additionally, it may exhibit pharmacokinetic properties such as absorption, distribution, metabolism, and excretion (ADME) that are crucial for its potential therapeutic applications. Safety profiles, including toxicity and side effects, are also important considerations in the development of NPY antagonists. Overall, this compound represents a significant area of interest in neuropharmacology and metabolic research.

Potent NPY Y1 antagonist & Y4 agonist; inhibits rat appetite; binds to NPFF receptors (Ki: 43-73 nM).

CAS 158859-98-4

Neuropeptide Y antagonist

GR231118

Ref: TM-TP2022